Biovest International Inc (BVTI) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
324 S HYDE PARK AVE TAMPA, FL 33606 |
| State of Incorp. | DE |
| Fiscal Year End | September 30 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
| 9/30/2013 | |||
|---|---|---|---|
| ASSETS | |||
| Current Assets | |||
| Cash, cash equivalents, and short-term investments | |||
| Cash and cash equivalents | |||
| Receivables | |||
| Inventory, net of allowances, customer advances and progress billings | |||
| Inventory | |||
| Costs in excess of billings | |||
| Other undisclosed current assets | |||
| Total current assets: | |||
| Noncurrent Assets | |||
| Property, plant and equipment | |||
| Intangible assets, net (including goodwill) | |||
| Goodwill | |||
| Intangible assets, net (excluding goodwill) | |||
| Other noncurrent assets | |||
| Other undisclosed noncurrent assets | |||
| Total noncurrent assets: | |||
| TOTAL ASSETS: | |||
| LIABILITIES AND EQUITY | |||
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | |||
| Accounts payable | |||
| Accrued liabilities | |||
| Debt | |||
| Other undisclosed current liabilities | |||
| Total current liabilities: | |||
| Noncurrent Liabilities | |||
| Long-term debt and lease obligation | |||
| Long-term debt, excluding current maturities | |||
| Capital lease obligations | |||
| Liabilities, other than long-term debt | |||
| Other liabilities | |||
| Total noncurrent liabilities: | |||
| Total liabilities: | |||
| Equity | |||
| Equity, attributable to parent | |||
| Common stock | |||
| Additional paid in capital | |||
| Accumulated deficit | |||
| Total equity: | |||
| TOTAL LIABILITIES AND EQUITY: | |||
Income Statement (P&L) (USD)
| 9/30/2013 | ||
|---|---|---|
| Gross profit: | ||
| Operating loss: | ||
| Loss from continuing operations: | ||
| Loss before gain (loss) on sale of properties: | ||
| Net loss available to common stockholders, diluted: | ||
Comprehensive Income (USD)
| 9/30/2013 | ||
|---|---|---|
| Net loss: | ||
| Comprehensive loss, net of tax, attributable to parent: | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.